Exelixis Inc. Common Stock vs Gerdau S.A. Common Stock — how do they compare? Exelixis Inc. Common Stock trades at $59.93 (market cap $14.62B), while Gerdau S.A. Common Stock trades at $5.08 (market cap $9.16B). The key difference: Exelixis Inc. Common Stock is the larger of the two by market cap, and Gerdau S.A. Common Stock pays a 3.67% dividend while Exelixis Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 0 Days and Gerdau S.A. Common Stock for 0 Days on average.
| EXEL | GGB | |
|---|---|---|
Market Cap | $14.62B | $9.16B |
Volume | 2,684,957 | 16,238,936 |
Sector | Health | Basic Materials |
52-Week High | $59.13 | $5.17 |
52-Week Low | $34.54 | $3.15 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $13.95B | $11.10B |
Dividend Yield | — | 3.67% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →Gerdau is a steel producer with operations across the Americas. It makes long steel, specialty steel, and other products for construction and industrial markets.
Read more on GGB →